United States Veterinary Ocular Medicine Market Size, by Route of Administration (2024-2032)

The distribution of veterinary ocular medications across oral, topical, and injectable routes reflects distinct adoption trends within the market. In 2024, topical administration dominated the U.S. veterinary ocular medicine market, valued at USD 151,764.26 thousand, significantly higher than oral (USD 64,608.29 thousand) and injectable (USD 34,436.02 thousand) segments, highlighting established clinical preferences. In 2025, the market is projected to reach USD 161,016.69 thousand for topical formulations, USD 68,123.59 thousand for oral, and USD 36,083.79 thousand for injectable routes, indicating steady year-on-year growth momentum.

From 2026 to 2032, market projections suggest that topical formulations are expected to expand to USD 271,731.84 thousand, followed by oral (USD 110,083.56 thousand) and injectable (USD 55,572.62 thousand) categories by 2032. These trends emphasise the growing preference for effective, easy-to-administer ocular treatments, driven by technological advancements and evolving veterinary care standards. Overall, the analysis highlights the expanding revenue potential and strategic opportunities for stakeholders aiming to strengthen product portfolios and enhance market positioning in the U.S. veterinary ocular medicine market.